Fernandez, Eve F.
HRN: 21-73-23 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2022
CEFUROXIME 1.5GM (VIAL)
08/07/2022
08/08/2022
IV
1.5grams
Q8h X 2 More Doses
SP Pelvic Lap
Waiting Final Action
Indication: ProphylaxisEmpirical De-escalation Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes